Roger Pomerantz Insider Trading $CFRX CONTRAFECT Corp

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Roger Pomerantz.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Roger Pomerantz. Roger Pomerantz is Director in Viracta Therapeutics, Inc. ($SNSS) and Chief Executive Officer in CONTRAFECT Corp ($CFRX) and Director in CONTRAFECT Corp ($CFRX) and Director in Seres Therapeutics, Inc. ($MCRB) and President and CEO in Seres Therapeutics, Inc. ($MCRB) and Director in Intec Pharma Ltd. ($NTEC) and Director in Rubius Therapeutics, Inc. ($RUBY).

Roger Pomerantz in CONTRAFECT Corp

Trading Symbol: CFRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Roger Pomerantz: Chief Executive Officer, Director
Holdings: 800 shares
Current Value: $1,360
Latest Transaction: Apr 13 2021
$CFRX Market Capitalization: $70.68M
$CFRX Previous Close: $1.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Roger Pomerantz in CONTRAFECT Corp

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CFRX, NTEC, RUBY, MCRB, SNSS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 13 2021	CFRX	CONTRAFECT Corp	Pomerantz Roger	Chief Executive Off ...	Option Exercise	A	4.31	254,000	1,094,740	254,000
Jul 26 2017	CFRX	CONTRAFECT Corp	Pomerantz Roger	Director	Option Exercise	P	1.55	400	620	400
Jul 26 2017	CFRX	CONTRAFECT Corp	Pomerantz Roger	Director	Buy	P	1.24	800	992	800	0 to 800

Page: 1